Sitero Unveils SiteroAI After StudyOS Acquisition: First AI-Powered CRO in Clinical Research

What Happened

Sitero, a technology-driven contract research organization (CRO), has acquired StudyOS, an integrated clinical trial management platform. Following the acquisition, Sitero has launched SiteroAI, a new solution that aims to automate and enhance clinical research operations with artificial intelligence tools. Sitero positions itself as the industry’s first truly AI-powered CRO, combining SiteroAI’s advanced capabilities with StudyOS technology to streamline clinical trials, data management, and regulatory compliance for clients in the healthcare and life sciences sectors.

Why It Matters

This move signals accelerating adoption of AI in clinical trials, with Sitero aiming to increase efficiency, data quality, and compliance within the pharmaceutical and healthcare industries. Enhanced AI integration could transform how research organizations manage and optimize complex studies, setting new standards for innovation in life sciences. Read more in our AI News Hub